VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of betting on a single drug pipeline. Right now, that diversification is being…
Retirees and income-focused investors have long used Vanguard Value ETF (NYSEARCA:VTV) as a core portfolio anchor, drawn to its dividend income, lower volatility relative to growth funds, and near-zero cost structure. When…
Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT), a pure-play sector fund that has quietly compounded wealth for long-term investors…
A 1.5% yield sounds unimpressive until you realize the dividend check doubles roughly every seven years. That is the premise behind the Vanguard Dividend Appreciation ETF (NYSEARCA:VIG): skip the high-yield traps and…
Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in opposite directions in 2026. With a 0.38% expense ratio, nearly $1.1 billion in net…
JPMorgan Dividend Leaders ETF (NYSEARCA:JDIV) launched in September 2024 with an appealing premise: a curated portfolio of global dividend leaders. The name implies income. The reality is a 1.59% yield at a…
Let’s cut through the noise on this dividend dream that keeps investors up at night. The key question many investors have is how much cash do you need parked in a portfolio to…
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of healthcare’s standout performers over the past year, with shares up 48% over the past 12 months and 16% year-to-date. The…
The stock market could face serious trouble as 2026 heads into the second quarter under duress. Extreme valuations collide with geopolitical tensions, AI investment skepticism, and policy headwinds. The Warren Buffett indicator…
Recession fears have a way of making income investors second-guess everything, and if dividends are paid out of cash flow, and cash flow shrinks during economic downturns, it only seems logical that…
The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and policy headwinds. The Warren Buffett indicator has surged to about 220%, far…
With the federal funds rate sitting at 3.75% and the 10-year Treasury yielding 4.13%, investors hunting for meaningful income have to venture well beyond government bonds. Three ETFs currently delivering above 10%…
DGRO has raised its annual dividend every single year since inception, through a pandemic, a rate-hiking cycle, and multiple bouts of market panic. For retirees building an income portfolio, that consistency matters…
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In…
The market’s fear gauge tells the story clearly. The VIX hit 21.15 as of March 4, 2026, up 29.4% in a single month. Consumer sentiment sits at 56.4 on the University of…
